Creating Value Through Breakthrough Science

NorthSea Therapeutics B.V. (“NorthSea” or the “Company”), a private, late-stage clinical biotechnology company leveraging its proprietary structurally engineered fatty acids (SEFAs) platform to develop novel drugs to treat rare liver diseases, has announced that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency’s (EMA) Committee for Orphan

Hitachi Energy, a global leader in electrification, and Pakal Technologies, a cutting-edge innovator in silicon power semiconductor design, announced a collaboration to advance shared value creation and sustainable growth. Hitachi Energy will incorporate Pakal Technologies’ groundbreaking Insulated Gate Turn-Off (Thyristor), IGTO(t)™, silicon power switch into its portfolio of market-leading high-voltage

biomodal, an omics-based life sciences technology and analytics company, announced at the AGBT 2026 General Meeting that biomodal’s duet multiomic solutions are compatible with Element Biosciences AVITI24™ 5D multiomics and AVITI™ sequencing instruments. Validated at the University of Minnesota (UMN) Genomics Center, this integration delivers enhanced sensitivity for applications including

At SmallSat Symposium 2026, VORAGO Technologies, a radiation-hardened and radiation-tolerant chip provider for space applications, announced a software partnership with wolfSSL, a company specializing in embedded cryptography for secure systems successfully for the last 20 years. This unique partnership delivers radiation-hardened chips with built-in, standards-based cryptographic security for orbital missions,

Glydways, a leading global Automated Transit Network (ATN), today announced a historic milestone in global mobility as they officially broke ground on its first publicly accessible system in South Metro Atlanta. Revealed during the South Metro Development Outlook Conference (SMDO26) in collaboration with ATL Airport Community Improvement Districts (AACIDs), the

Dubai’s Roads and Transport Authority (RTA) has signed a cooperation agreement with Glydways, a global leader in Automated Transit Networks (ATN). The agreement marks the launch of the first automated programme for an automated transit network, introducing a new model of smart and sustainable mobility in Dubai. The initiative supports

PlanetiQ, an innovator in satellite weather data, has announced that NASA’s Commercial Satellite Data Acquisition (CSDA) Program completed a one-year independent evaluation of PlanetiQ’s radio occultation data, resulting in highly favorable findings. The assessment rated PlanetiQ’s total electron content (TEC) precision as “best-in-class” and identified its very high signal-to-noise ratio

biomodal, an omics-based life sciences technology and analytics company, has announced the publication of a study in Nature Communications Medicine showcasing how the combination of methylation and hydroxymethylation biomarkers, using its proprietary duet multiomic technology, improves the earlier detection of colorectal cancer (CRC) via liquid biopsy. The study demonstrates that

Antevia Networks, the telecoms equipment vendor changing the economics of 5G private networks, has announced the successful deployment of its 5G Shift end-to-end private network at Premiership Rugby Champions Bath Rugby's historic Recreation Ground. The new 5G private network delivers low-cost, high-performance, predictable connectivity across the entire stadium and fan

Eli Lilly and Company (NYSE: LLY) and Ventyx Biosciences, Inc. (Nasdaq: VTYX), a San Diego-based clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with inflammatory-mediated diseases, have announced entry into a definitive agreement for Lilly to acquire Ventyx. Ventyx is developing a pipeline of small molecule therapeutics,

Paragraf, the UK-based company pioneering the commercialization of graphene-based electronics using standard semiconductor processes, has successfully produced the first 6-inch wafer at its new manufacturing facility in Huntingdon, marking a significant expansion in the company’s production capability and technology platform. The wafer contains graphene field-effect transistors (GFETs) fabricated using Paragraf’s

Long Wall has announced Cyclops: a new, surface-launched, exoatmospheric interceptor to defeat missiles in the midcourse phase of flight. Cyclops will provide high-performance, low-cost magazine depth for homeland and regional missile defense. A mission to defer and defeat As Long Wall’s flagship interceptor, Cyclops underpins our mission to accelerate missile

Novadip Biosciences, a late-stage clinical biotechnology company specializing in regenerative medicine, has announced the recruitment of the first pediatric patients for the pivotal phase 3 trial of its tissue regeneration product NVD003 in congenital pseudoarthrosis of the tibia (CPT). Phoenix Children’s Hospital, (Phoenix, AZ, USA), and Cliniques universitaires Saint-Luc, (Brussels,

Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with inflammation-mediated cardiovascular and neurodegenerative diseases, has announced that the Company added two leading experts to their advisory board and provided an update to its ongoing Phase 2 study of VTX2735

Resolve Therapeutics, a mid-stage clinical biopharmaceutical company pioneering non-immunosuppressive drugs for inflammatory diseases has announced it will highlight its platform and clinical progress in a presentation entitled “Cell-free Nucleic Acids as Drug Targets in Autoimmunity and Acute Brain Injury”. Dr. James Posada, chief executive officer of Resolve Therapeutics will present

The booming satellite industry just received a massive cost-saving injection paired with unprecedented ease of integration. VORAGO Technologies has announced a world first: the launch of four radiation-tolerant microcontrollers purpose-built for low Earth orbit (LEO) markets at a fraction of the cost of traditional space-grade components, with first chips shipping

Abu Dhabi Investment Office (ADIO) has signed a strategic partnership with Glydways, Inc. (Glydways) a leading global Automated Transit Network (ATN), to explore the deployment of its innovative transit systems across Abu Dhabi. The collaboration, which builds on momentum from the recent Abu Dhabi Investment Forum in New York, marks

Zeotap, the next-generation Customer Data Platform (CDP), has been awarded the ISO/IEC 27001 certification after meeting the stringent requirements for establishing, implementing, maintaining and continually improving an information security management system (ISMS) as put forward by the International Organization for Standardization (ISO). Zeotap India has been awarded the certification for

Digital Catapult has welcomed six international Open RAN (Radio Access Network) vendors to its advanced connectivity programme, driving the development, deployment and diversification of data-driven and open future networks in the UK. The next phase of the programme will support vendors to trial real-world products and services for scaling and

Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), has announced positive results from its Phase 2 study of oral, once-daily VTX3232 in patients with Obesity and Cardiovascular Risk Factors. The 175- participant study examined VTX3232 versus placebo, alone or in combination with semaglutide, evaluating safety and tolerability as the primary endpoint,